Elite Pharmaceuticals Files 8-K
Ticker: ELTP · Form: 8-K · Filed: Mar 3, 2025 · CIK: 1053369
| Field | Detail |
|---|---|
| Company | Elite Pharmaceuticals INC /NV/ (ELTP) |
| Form Type | 8-K |
| Filed Date | Mar 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, filing
TL;DR
Elite Pharma filed an 8-K on Feb 28, 2025. Details pending.
AI Summary
Elite Pharmaceuticals, Inc. filed an 8-K on March 3, 2025, reporting events as of February 28, 2025. The filing primarily concerns Regulation FD Disclosure and includes Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This filing indicates Elite Pharmaceuticals is providing updates or disclosures to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for disclosures and exhibits, with no immediate indication of significant negative events.
Key Players & Entities
- ELITE PHARMACEUTICALS INC /NV/ (company) — Registrant
- Nevada (jurisdiction) — State of incorporation
- New Jersey (jurisdiction) — State of principal executive offices
FAQ
What specific information is being disclosed under Regulation FD?
The provided excerpt does not detail the specific content of the Regulation FD Disclosure.
Are there any new financial statements included with this filing?
The filing indicates that Financial Statements and Exhibits are included, but the excerpt does not provide them.
What is the exact date of the earliest event reported?
The date of the earliest event reported is February 28, 2025.
What is Elite Pharmaceuticals' principal executive office address?
The principal executive offices are located at 165 Ludlow Avenue, Northvale, New Jersey 07647.
Has Elite Pharmaceuticals changed its name or former company status recently?
The filing notes a former company name of 'ELITE PHARMACEUTICALS INC /DE/' with a date of name change as January 21, 1998, indicating this is not a recent change.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 3, 2025 regarding ELITE PHARMACEUTICALS INC /NV/ (ELTP).